(2R)-2-[(5-bromo-4-chloro-2-fluorophenyl)sulfonyl-methylamino]-3-methyl-N-phenylbutanamide
C18H19BrClFN2O3S — CID 171450688
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-[(5-bromo-4-chloro-2-fluorophenyl)sulfonyl-methylamino]-3-methyl-N-phenylbutanamide
(2R)-2-[(5-bromo-4-chloro-2-fluorophenyl)sulfonyl-methylamino]-3-methyl-N-phenylbutanamide (PubChem CID 171450688) has the molecular formula C18H19BrClFN2O3S and a molecular weight of 477.78 g/mol. Its IUPAC name is (2R)-2-[(5-bromo-4-chloro-2-fluorophenyl)sulfonyl-methylamino]-3-methyl-N-phenylbutanamide.
Molecular Properties
| Compound Name | (2R)-2-[(5-bromo-4-chloro-2-fluorophenyl)sulfonyl-methylamino]-3-methyl-N-phenylbutanamide |
|---|---|
| PubChem CID | 171450688 |
| Molecular Formula | C18H19BrClFN2O3S |
| Molecular Weight | 477.78 g/mol |
| Exact Mass | 476.00 |
| IUPAC Name | (2R)-2-[(5-bromo-4-chloro-2-fluorophenyl)sulfonyl-methylamino]-3-methyl-N-phenylbutanamide |
| SMILES | CC(C)[C@H](C(=O)Nc1ccccc1)N(C)S(=O)(=O)c1cc(Br)c(Cl)cc1F |
| InChI | InChI=1S/C18H19BrClFN2O3S/c1-11(2)17(18(24)22-12-7-5-4-6-8-12)23(3)27(25,26)16-9-13(19)14(20)10-15(16)21/h4-11,17H,1-3H3,(H,22,24)/t17-/m1/s1 |
| InChIKey | KVSNTZDJHRPAPI-QGZVFWFLSA-N |
| XLogP | 4.53 |
| TPSA | 66.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 477.78 |
| LogP ≤ 5 | 4.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171450688 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.